Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332635 | 0.95 | — | — | |
| SCHEMBL11741822 | 0.87 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL15957864 | 0.81 | AR (0.32) | SMN1; SMN2NR1H3NR1H2 | |
| SCHEMBL11745002 | 0.78 | ALDH1A1 (0.34) | SMN1; SMN2CYP1A2 | |
| SCHEMBL1334127 | 0.78 | GLRA3 (0.38) | SMN1; SMN2 | |
| SCHEMBL1332783 | 0.77 | ASPH (0.33) | SMN1; SMN2 | |
| SCHEMBL1333169 | 0.77 | ASPH (0.33) | SMN1; SMN2 | |
| SCHEMBL9142308 | 0.75 | GPR35 (0.38) | SMN1; SMN2CYP1A2 | |
| SCHEMBL1332868 | 0.73 | CYP1A2 (0.44) | SMN1; SMN2CYP1A2NR1H3NR1H2 | |
| SCHEMBL1332638 | 0.72 | KCNJ11 (0.35) | SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304508-B2 | Fluorine-containing dicarboxylic acids and their novel polymer compounds | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20110282026-A1 | Fluorine-Containing Dicarboxylic Acids and Their Novel Polymer Compounds | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-11-17 | — | — | US | disclosed |
| US-8003749-B2 | Fluorine-containing dicarboxylic acids and their novel polymer compounds | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-08-23 | — | — | US | disclosed |
| US-20090030173-A1 | NOVEL FLUORINE-CONTAINING DICARBOXYLIC ACIDS AND THEIR NOVEL POLYMER COMPOUNDS | CENTRAL GLASS COMPANY, LIMITED (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030173-A1 | NOVEL FLUORINE-CONTAINING DICARBOXYLIC ACIDS AND THEIR NOVEL POLYMER COMPOUNDS | AFF1, ODC1, DDC | SMN1; SMN2 2624/4885CYP1A2 2198/4885NR1H3 4052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.